[
  {
    "id": "ev-001",
    "title": "Treatment-Resistant Depression: Evidence-Based Sequencing Strategies",
    "snippet": "Guideline summary supports stepwise optimization, augmentation, and consideration of advanced therapies after multiple adequate antidepressant trials.",
    "sourceName": "Consensus Review (Mock)",
    "year": 2023,
    "urlPlaceholder": "url:mock://evidence/ev-001",
    "tags": ["depression", "TRD", "guideline", "sequencing"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-002",
    "title": "Esketamine for TRD: Induction and Maintenance Outcomes",
    "snippet": "Randomized evidence demonstrates symptom improvement with supervised administration and ongoing monitoring in TRD populations.",
    "sourceName": "Journal of Clinical Psych (Mock)",
    "year": 2022,
    "urlPlaceholder": "url:mock://evidence/ev-002",
    "tags": ["depression", "TRD", "esketamine", "spravato"],
    "specialty": "Psychiatry",
    "strengthLevel": "High"
  },
  {
    "id": "ev-003",
    "title": "Adult ADHD Pharmacotherapy: Long-Term Safety Considerations",
    "snippet": "Longitudinal findings support continued efficacy with appropriate cardiovascular screening and dose monitoring.",
    "sourceName": "NEJM (Mock)",
    "year": 2021,
    "urlPlaceholder": "url:mock://evidence/ev-003",
    "tags": ["ADHD", "stimulant", "adult", "safety"],
    "specialty": "Psychiatry",
    "strengthLevel": "High"
  },
  {
    "id": "ev-004",
    "title": "Bipolar I: Acute Mania Management Algorithm",
    "snippet": "Algorithm recommends mood stabilizer + atypical antipsychotic for acute mania, with maintenance planning after stabilization.",
    "sourceName": "APA Guideline (Mock)",
    "year": 2022,
    "urlPlaceholder": "url:mock://evidence/ev-004",
    "tags": ["bipolar", "mania", "guideline"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-005",
    "title": "Generalized Anxiety Disorder: CBT vs Medication",
    "snippet": "Combined CBT + pharmacotherapy shows improved outcomes in severe presentations compared to monotherapy in multiple trials.",
    "sourceName": "Lancet Psychiatry (Mock)",
    "year": 2020,
    "urlPlaceholder": "url:mock://evidence/ev-005",
    "tags": ["anxiety", "GAD", "CBT", "SSRI"],
    "specialty": "Psychiatry",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-006",
    "title": "Major Depressive Disorder: PHQ-9 Use for Monitoring",
    "snippet": "Routine PHQ-9 tracking can support measurement-based care and earlier identification of non-response.",
    "sourceName": "Primary Care Update (Mock)",
    "year": 2019,
    "urlPlaceholder": "url:mock://evidence/ev-006",
    "tags": ["depression", "PHQ-9", "measurement-based care"],
    "specialty": "Family Medicine",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-007",
    "title": "PTSD: First-Line Therapies and When to Escalate",
    "snippet": "Evidence supports trauma-focused psychotherapy; medication considered when psychotherapy is insufficient or unavailable.",
    "sourceName": "Practice Bulletin (Mock)",
    "year": 2021,
    "urlPlaceholder": "url:mock://evidence/ev-007",
    "tags": ["PTSD", "therapy", "SSRI"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-008",
    "title": "Obsessive-Compulsive Disorder: SSRI Dose Optimization",
    "snippet": "Higher SSRI dosing ranges and adequate duration are associated with improved response in OCD.",
    "sourceName": "Clinical Review (Mock)",
    "year": 2018,
    "urlPlaceholder": "url:mock://evidence/ev-008",
    "tags": ["OCD", "SSRI", "dose"],
    "specialty": "Psychiatry",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-009",
    "title": "Schizophrenia: Maintenance Antipsychotic Adherence Strategies",
    "snippet": "Adherence interventions including shared decision-making and side-effect mitigation reduce relapse risk.",
    "sourceName": "Systematic Review (Mock)",
    "year": 2020,
    "urlPlaceholder": "url:mock://evidence/ev-009",
    "tags": ["schizophrenia", "adherence", "antipsychotic"],
    "specialty": "Psychiatry",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-010",
    "title": "Suicide Risk: Safety Planning as Standard of Care",
    "snippet": "Safety planning interventions reduce suicidal behavior when implemented with follow-up and means-restriction counseling.",
    "sourceName": "Clinical Guidance (Mock)",
    "year": 2021,
    "urlPlaceholder": "url:mock://evidence/ev-010",
    "tags": ["suicide", "safety", "risk"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-011",
    "title": "ADHD: Step Therapy and Clinical Exceptions",
    "snippet": "Clinical exceptions may be supported by documented intolerance, functional impairment, and prior trial outcomes.",
    "sourceName": "Payer Policy Summary (Mock)",
    "year": 2024,
    "urlPlaceholder": "url:mock://evidence/ev-011",
    "tags": ["ADHD", "step therapy", "payer"],
    "specialty": "Psychiatry",
    "strengthLevel": "Low"
  },
  {
    "id": "ev-012",
    "title": "Depression: Augmentation Strategies After SSRI Failure",
    "snippet": "Augmentation with atypical antipsychotics or bupropion is supported in subsets when monotherapy is insufficient.",
    "sourceName": "Meta-analysis (Mock)",
    "year": 2017,
    "urlPlaceholder": "url:mock://evidence/ev-012",
    "tags": ["depression", "augmentation", "SSRI"],
    "specialty": "Psychiatry",
    "strengthLevel": "High"
  },
  {
    "id": "ev-013",
    "title": "Bipolar Depression: Atypical Antipsychotics Evidence Summary",
    "snippet": "Certain atypical antipsychotics show efficacy in bipolar depression; monitoring for metabolic effects is recommended.",
    "sourceName": "Evidence Brief (Mock)",
    "year": 2019,
    "urlPlaceholder": "url:mock://evidence/ev-013",
    "tags": ["bipolar", "depression", "atypical antipsychotic"],
    "specialty": "Psychiatry",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-014",
    "title": "Insomnia: CBT-I as First-Line",
    "snippet": "CBT-I improves sleep outcomes and is recommended before long-term sedative-hypnotic use.",
    "sourceName": "Sleep Medicine Guideline (Mock)",
    "year": 2020,
    "urlPlaceholder": "url:mock://evidence/ev-014",
    "tags": ["insomnia", "CBT-I", "sleep"],
    "specialty": "Family Medicine",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-015",
    "title": "Medication Adherence: Shared Decision-Making Improves Outcomes",
    "snippet": "Shared decision-making can improve adherence and patient satisfaction across chronic conditions.",
    "sourceName": "Health Services Research (Mock)",
    "year": 2016,
    "urlPlaceholder": "url:mock://evidence/ev-015",
    "tags": ["adherence", "shared decision-making"],
    "specialty": "General",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-016",
    "title": "Anxiety Disorders: SSRI Onboarding and Side-Effect Counseling",
    "snippet": "Counseling about transient side effects and gradual titration may reduce early discontinuation.",
    "sourceName": "Clinical Toolkit (Mock)",
    "year": 2019,
    "urlPlaceholder": "url:mock://evidence/ev-016",
    "tags": ["anxiety", "SSRI", "titration"],
    "specialty": "Psychiatry",
    "strengthLevel": "Low"
  },
  {
    "id": "ev-017",
    "title": "OCD: ERP Therapy Effectiveness",
    "snippet": "Exposure and response prevention (ERP) demonstrates meaningful improvement and can be combined with SSRIs.",
    "sourceName": "Therapy Review (Mock)",
    "year": 2018,
    "urlPlaceholder": "url:mock://evidence/ev-017",
    "tags": ["OCD", "ERP", "therapy"],
    "specialty": "Psychiatry",
    "strengthLevel": "High"
  },
  {
    "id": "ev-018",
    "title": "Depression: Criteria for Adequate Antidepressant Trial",
    "snippet": "Adequate trial typically includes sufficient dose and duration with adherence; documentation supports payer review.",
    "sourceName": "Clinical Reference (Mock)",
    "year": 2015,
    "urlPlaceholder": "url:mock://evidence/ev-018",
    "tags": ["depression", "adequate trial", "documentation"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-019",
    "title": "Substance Use: Screening and Brief Intervention",
    "snippet": "Routine screening supports identification of comorbid substance use that can affect psychiatric treatment outcomes.",
    "sourceName": "USPSTF Summary (Mock)",
    "year": 2020,
    "urlPlaceholder": "url:mock://evidence/ev-019",
    "tags": ["substance use", "screening", "comorbidity"],
    "specialty": "General",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-020",
    "title": "ADHD: Comparative Efficacy of Extended-Release Stimulants",
    "snippet": "Extended-release stimulants can reduce rebound symptoms and support functional coverage across the day.",
    "sourceName": "Comparative Review (Mock)",
    "year": 2019,
    "urlPlaceholder": "url:mock://evidence/ev-020",
    "tags": ["ADHD", "stimulant", "extended-release"],
    "specialty": "Psychiatry",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-021",
    "title": "Bipolar I: Maintenance Therapy and Relapse Prevention",
    "snippet": "Maintenance treatment reduces relapse risk; monitoring for side effects and adherence is essential.",
    "sourceName": "Guideline Update (Mock)",
    "year": 2021,
    "urlPlaceholder": "url:mock://evidence/ev-021",
    "tags": ["bipolar", "maintenance", "relapse prevention"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-022",
    "title": "Depression: When to Consider Advanced Therapies",
    "snippet": "Advanced therapies may be considered after multiple adequate trials with persistent functional impairment.",
    "sourceName": "Practice Guide (Mock)",
    "year": 2022,
    "urlPlaceholder": "url:mock://evidence/ev-022",
    "tags": ["depression", "advanced therapy", "TRD"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-023",
    "title": "Psychiatric Hospitalization: Risk Stratification Notes",
    "snippet": "Past hospitalization can indicate elevated risk and supports careful safety planning and treatment intensity decisions.",
    "sourceName": "Clinical Notes (Mock)",
    "year": 2018,
    "urlPlaceholder": "url:mock://evidence/ev-023",
    "tags": ["hospitalization", "risk", "safety"],
    "specialty": "Psychiatry",
    "strengthLevel": "Low"
  },
  {
    "id": "ev-024",
    "title": "Comorbidities: Managing Metabolic Risk in Atypical Antipsychotic Use",
    "snippet": "Baseline metabolic screening and periodic monitoring are recommended to mitigate cardiometabolic risks.",
    "sourceName": "Safety Guidance (Mock)",
    "year": 2017,
    "urlPlaceholder": "url:mock://evidence/ev-024",
    "tags": ["comorbidity", "metabolic", "antipsychotic", "safety"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-025",
    "title": "Anxiety: Benzodiazepine Caution in Long-Term Use",
    "snippet": "Long-term use may be associated with dependence; alternatives and taper planning should be considered.",
    "sourceName": "Safety Bulletin (Mock)",
    "year": 2016,
    "urlPlaceholder": "url:mock://evidence/ev-025",
    "tags": ["anxiety", "benzodiazepine", "safety"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-026",
    "title": "Depression: Functional Impairment Documentation Tips",
    "snippet": "Documenting work/school impairment and ADLs can support medical necessity narratives in payer reviews.",
    "sourceName": "Documentation Guide (Mock)",
    "year": 2024,
    "urlPlaceholder": "url:mock://evidence/ev-026",
    "tags": ["depression", "documentation", "function"],
    "specialty": "General",
    "strengthLevel": "Low"
  },
  {
    "id": "ev-027",
    "title": "ADHD: Non-Stimulant Options Overview",
    "snippet": "Non-stimulants may be appropriate for certain comorbidities or intolerance; onset and efficacy differ from stimulants.",
    "sourceName": "Clinical Review (Mock)",
    "year": 2020,
    "urlPlaceholder": "url:mock://evidence/ev-027",
    "tags": ["ADHD", "non-stimulant", "atomoxetine"],
    "specialty": "Psychiatry",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-028",
    "title": "Bipolar I: Cariprazine Efficacy Snapshot",
    "snippet": "Evidence supports efficacy in bipolar disorder symptom domains; dosing and tolerability should be individualized.",
    "sourceName": "Trial Summary (Mock)",
    "year": 2019,
    "urlPlaceholder": "url:mock://evidence/ev-028",
    "tags": ["bipolar", "cariprazine", "vraylar"],
    "specialty": "Psychiatry",
    "strengthLevel": "Moderate"
  },
  {
    "id": "ev-029",
    "title": "Depression: Safety Monitoring in Advanced Therapies",
    "snippet": "Protocols emphasize monitoring, follow-up cadence, and safety checks for patients receiving advanced interventions.",
    "sourceName": "Protocol Checklist (Mock)",
    "year": 2023,
    "urlPlaceholder": "url:mock://evidence/ev-029",
    "tags": ["depression", "safety", "protocol"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-030",
    "title": "Clinical Documentation QA: Common Missing Elements",
    "snippet": "Common gaps include missing severity scales, unclear duration, absent prior treatment outcomes, and limited safety assessment notes.",
    "sourceName": "QA Playbook (Mock)",
    "year": 2024,
    "urlPlaceholder": "url:mock://evidence/ev-030",
    "tags": ["documentation", "QA", "checklist"],
    "specialty": "General",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-spravato-001",
    "title": "FDA label summary (mock): Esketamine indication for TRD and required monitoring",
    "snippet": "Mock label summary: Esketamine nasal spray is indicated for TRD under supervised administration with post-dose observation and safety monitoring per clinic protocol.",
    "sourceName": "FDA Label Summary (Mock)",
    "year": 2025,
    "urlPlaceholder": "url:mock://evidence/ev-spravato-001",
    "tags": ["esketamine", "spravato", "TRD", "label", "monitoring"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-spravato-002",
    "title": "Guideline snippet (mock): TRD definition and adequate trial criteria",
    "snippet": "Mock guideline: TRD may be defined by non-response to multiple adequate antidepressant trials with persistent functional impairment and validated severity scores.",
    "sourceName": "Clinical Guideline (Mock)",
    "year": 2024,
    "urlPlaceholder": "url:mock://evidence/ev-spravato-002",
    "tags": ["TRD", "guideline", "adequate trial", "documentation"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  },
  {
    "id": "ev-spravato-003",
    "title": "Efficacy evidence (mock): Esketamine outcomes in TRD",
    "snippet": "Mock evidence: RCT and real-world summaries demonstrate clinically meaningful symptom improvement in TRD with appropriate induction/maintenance and monitoring.",
    "sourceName": "Efficacy Summary (Mock)",
    "year": 2023,
    "urlPlaceholder": "url:mock://evidence/ev-spravato-003",
    "tags": ["esketamine", "TRD", "efficacy", "outcomes"],
    "specialty": "Psychiatry",
    "strengthLevel": "High"
  },
  {
    "id": "ev-spravato-004",
    "title": "Safety & REMS-style notes (mock): observation workflow and risk mitigation",
    "snippet": "Mock safety notes: Clinic-based observation and post-dose monitoring with documented safety planning and follow-up reduce avoidable risk and support payer requirements.",
    "sourceName": "Safety / REMS Notes (Mock)",
    "year": 2024,
    "urlPlaceholder": "url:mock://evidence/ev-spravato-004",
    "tags": ["safety", "REMS", "monitoring", "risk"],
    "specialty": "Psychiatry",
    "strengthLevel": "Consensus"
  }
]


